Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance. | Mol Pharm;4(1): 140-53, 2007. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance.

Battisti, Robert F; Zhong, Yanqiang; Fang, Lanyan; Gibbs, Seth; Shen, Jie; Nadas, Janos; Zhang, Guisheng; Sun, Duxin.

Affiliation

Battisti RF; Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.

Mol Pharm ; 4(1): 140-53, 2007.

Article in En | MEDLINE | ID: mdl-17274671

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Daunorubicin / ATP Binding Cassette Transporter, Subfamily B, Member 1 / Drug Resistance, Multiple / Carbohydrate Metabolism Limits: Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2007 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Daunorubicin / ATP Binding Cassette Transporter, Subfamily B, Member 1 / Drug Resistance, Multiple / Carbohydrate Metabolism Limits: Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2007 Document type: Article Affiliation country: Country of publication: